全文获取类型
收费全文 | 97584篇 |
免费 | 8249篇 |
国内免费 | 2561篇 |
专业分类
耳鼻咽喉 | 1152篇 |
儿科学 | 2314篇 |
妇产科学 | 2836篇 |
基础医学 | 8620篇 |
口腔科学 | 2412篇 |
临床医学 | 12845篇 |
内科学 | 11718篇 |
皮肤病学 | 1600篇 |
神经病学 | 7507篇 |
特种医学 | 1975篇 |
外国民族医学 | 10篇 |
外科学 | 8538篇 |
综合类 | 12478篇 |
现状与发展 | 4篇 |
一般理论 | 12篇 |
预防医学 | 11361篇 |
眼科学 | 2088篇 |
药学 | 8894篇 |
140篇 | |
中国医学 | 5931篇 |
肿瘤学 | 5959篇 |
出版年
2024年 | 294篇 |
2023年 | 1766篇 |
2022年 | 2997篇 |
2021年 | 4222篇 |
2020年 | 4198篇 |
2019年 | 4126篇 |
2018年 | 3861篇 |
2017年 | 3913篇 |
2016年 | 3781篇 |
2015年 | 3495篇 |
2014年 | 6305篇 |
2013年 | 7758篇 |
2012年 | 5522篇 |
2011年 | 5999篇 |
2010年 | 4672篇 |
2009年 | 4617篇 |
2008年 | 4531篇 |
2007年 | 4509篇 |
2006年 | 3920篇 |
2005年 | 3454篇 |
2004年 | 2880篇 |
2003年 | 2659篇 |
2002年 | 2002篇 |
2001年 | 1862篇 |
2000年 | 1512篇 |
1999年 | 1319篇 |
1998年 | 1140篇 |
1997年 | 1096篇 |
1996年 | 1010篇 |
1995年 | 942篇 |
1994年 | 774篇 |
1993年 | 674篇 |
1992年 | 617篇 |
1991年 | 519篇 |
1990年 | 540篇 |
1989年 | 465篇 |
1988年 | 346篇 |
1987年 | 298篇 |
1986年 | 354篇 |
1985年 | 466篇 |
1984年 | 441篇 |
1983年 | 269篇 |
1982年 | 348篇 |
1981年 | 282篇 |
1980年 | 298篇 |
1979年 | 219篇 |
1978年 | 182篇 |
1977年 | 173篇 |
1976年 | 161篇 |
1975年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
Two topical corticosteroids, budesonide (BUD) and beclomethasone dipropionate (BDP), both administered as suspensions in water, were investigated in healthy volunteers regarding influence on cortisol in plasma and urine (U-cortisol) after nasal application. In the first study, single doses of 200, 400, and 800 μg of BDP and BUD were given at 10:00 pm. In the second study, 100, 200, and 400 μg were given mornings and evenings for 4 days. In the single-dose study, none of the drugs or doses showed any significant influence on cortisol in plasma. However, U-cortisol decreased significantly after BUD 400 and 800 μg. In the multidose study, U-cortisol values were significantly reduced after all doses of BUD and the highest dose of BDP. The compounds tested showed different ability to cause measurable systemic effects after nasal application. The clinical implication is that the prescriber, when choosing a compound, should take the application site into consideration and should also be encouraged to find the lowest effective dose. 相似文献
122.
Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations 总被引:2,自引:0,他引:2
The county of Vestfold in the South-eastern part of Norway has undergone two incidence and prevalence surveys on multiple sclerosis. The prevalence of definite/probable MS on January 1.1963 was 61.6/100000. Based on the same diagnostic criteria, the present study reports a slight increase in prevalence to 86.4/100000 on January 1st 1983. The average annual incidence was calculated for 5 years periods from 1953 to 1983. The time periods 1953–1962 and 1973–1977 showed age-adjusted incidence rates between 4.50 and 5.49/100000 while the 10–year period 1963–1972 showed significantly lower rates. The fluctuating pattern of MS incidence and prevalence over time supports the view that MS is not a stable disease, and that exogenous factors are influencing the disease pattern. 相似文献
123.
LYNDA E ALBERTYN 《Journal of Medical Imaging and Radiation Oncology》1992,36(1):17-22
Both systemic and local therapy, for conditions of the breast and unrelated to it, may produce manuno-graphic changes. Some of these are characteristic, such as the pattern of scarring seen in reduction mammo-plasty. In many other instances, however, the changes produced overlap features commonly seen in malignancy. A knowledge of the timing, natural history and spectrum of these changes will aid mammographic interpretation. 相似文献
124.
Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency. 下载免费PDF全文
J A Rump A Jahreis M Schlesier R Drger I Melchers H H Peter 《Clinical and experimental immunology》1992,89(2):204-210
Common variable immunodeficiency (CVID) patients are unable to produce specific immunoglobulins after antigen contact in vivo. The aim of this study was to investigate whether in some cases of CVID a decreased de novo synthesis of IL-2 might be the cause of immunodeficiency and whether this deficiency can be corrected by IL-2 supplementation in vitro. Mononuclear cells from 17 CVID patients and from 10 healthy controls were cultured with monoclonal anti-CD3 antibody OKT3, pokeweed mitogen (PWM) or tetanus toxoid (TT) to stimulate IL-2 synthesis. In parallel, in vitro IgG and IgM synthesis was stimulated with Staphylococcus aureus Cowan I (SAC), PWM or TT in the presence or absence of IL-2. While lymphocytes of 11 out of 17 patients produced low to normal amounts of IL-2 upon stimulation with anti-CD3, only three patients showed low IL-2 production in response to PWM and five in response to TT. Regarding immunoglobulin synthesis in vitro, five patients completely failed to produce IgM or IgG upon stimulation with PWM, SAC or TT irrespective of the addition of IL-2. By contrast, four patients did not show any defect in vitro and synthesized normal amounts of IgM and IgG with any of the three stimuli. Finally, eight patients could be reconstituted for PWM-, SAC- and TT-induced IgM and/or IgG synthesis in vitro, by adding IL-2 to the culture system. This enhancing effect of IL-2 could be blocked by adding anti-IL-2 receptor antibodies to the cultures. Our findings indicate that a defective IL-2 synthesis after antigen stimulation may be one reason for the impaired immunoglobulin production in some cases of CVID. 相似文献
125.
B. Stray-Pedersen 《International urogynecology journal》1990,1(2):100-103
The paper gives an overview of today's knowledge of urinary tract infection in pregnancy and different treatment procedures. Three different studies of urinary tract infection (UTI) in pregnancy and the postpartum period are reported. Urinary screening of 1798 pregnant women showed a cumulative frequency of bacteriuria of 4.8%, recurrent infection in one-fifth of the cases, and pyelonephritis in 0.6%. Chlamydial infection was observed as a cause of dysuria in pregnancy. In the postpartum period bladder bacteriuria was demonstrated in 3.7%. The condition persisted in 27%, while short-course treatment had significant effect.Presented at the Zambon Symposium on Bacteriuria in Pregnancy, International Urogynecological Association Annual Meeting, Riva del Garda, Italy, September 13, 1989. 相似文献
126.
H. Isoniemi J. Ahonen B. Eklund K. Höckerstedt K. Salmela E. von Willebrand P. Häyry 《Transplant international》1990,3(1):121-127
Abstract. A prospective randomized study was conducted to evaluate the impact of four different conversion protocols on graft outcome in long-term follow-up. Between January 1986 and May 1987, 128 patients with first cadaveric kidney allografts were randomized at the time of transplantation to four treatment groups of 32 patients each, to be assigned 10 weeks post-transplantation. During the first 10 weeks, all patients received triple therapy with low-dose azathioprine (Aza), cyclosporin (CyA), and methylprednisolone (MP). After 10 weeks, one group continued with triple therapy (group A) while the three other groups received different combinations of two drugs, namely, Aza and CyA (group B), Aza and MP (group C), or CyA and MP (group D). Withdrawal of MP (group B) or especially of CyA (group C) was associated with 4/29 (14%) and 10/28 (36%) acute rejection episodes, respectively, for 60 days after conversion. All rejections were mild and reversible. There were no rejections after Aza withdrawal or in the group that continued on triple therapy during the corresponding time period. The most common reason for dropping out after withdrawal, for those patients who could not continue on the originally randomized medication, was azathioprine intolerance (n= 12). Five patients were switched back to triple therapy after CyA withdrawal due to rejection. Steroid intolerance was rare and CyA in low doses was very well tolerated. At 1 year there were no statistically significant differences in graft survival between groups A, B, C, and D-81 %, 88%, 88%, and 88%, respectively-or in patient survival-88%, 88%, 88%, and 97%, respectively. For those patients continuing with the originally randomized treatment protocol, there were no differences in patient or graft survival either, the means being 91% and 89%, respectively. The most common cause of death after withdrawal was cardiovascular in nature, and there were no more fatal infections under triple drug treatment than with double drug regimens. There were no statistically significant differences in mean serum creatinine values at 1 year. The median serum creatinine values for groups A, B, C, and D were 112, 132, 133, and 133 μmol/l, respectively. At 1 year the mean CyA dose in the groups that continued with CyA was 3. 5–4. 2 mg/kg per day and CyA concentrations were equal. 相似文献
127.
The effect of sodium lauryl sulphate (SLS) on cytokeratin (CK) gene expression in hamster cheek pouch epithelium was studied with a hybridohistochemical technique. Using specific human anti-sense RNA probes, the plausible hamster mRNA counterparts for these human CK mRNAs were localized by detection of heterologous hybrids. In comparison with normal epithelium, the expression and distribution pattern of CK mRNAs in the hamster cheek pouch were obviously changed after application of SLS. There was a decreased expression of CK mRNAs in the hyperplastic basal layer, and increased expression in the hypertrophic granular layer. Strikingly, hybridization with the human CK 18 cRNA probe revealed an additionally expressed CK mRNA in the SLS-treated epithelium that was not found in the untreated epithelium. The present study indicates that cRNA probes for human CK mRNAs can be used successfully, not only to distinguish between different hamster CK mRNAs but also to investigate changes in CK gene expression upon the induction of non-neoplastic and neoplastic alterations in the hamster cheek pouch model. This may help elucidate the molecular changes involved in epithelial pathologies. 相似文献
128.
I. Wiklund F. Waagstein K. Swedberg Å. Hjalmarsson 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1996,10(3):361-368
Summary Quality of life in heart failure patients is receiving increased attention as a reflection of a treatment's potential secondary
benefit of general well-being and daily functioning. The Metoprolol in Dilated Cardiomyopathy (MDC) trial was conducted as
a large, multicenter trial to establish the effects of metoprolol on mortality and need for heart transplantation in patients
with symptomatic idiopathic cardiomyopathy. It was found that metoprolol was well tolerated, improved symptoms and cardiac
function, and prevented clinical deterioration in patients with symptomatic idiopathic dilated cardiomyopathy. Quality of
life was evaluated as a secondary endpoint in 345 out of 383 randomized patients using a disease-specific questionnaire, the
Quality of Life in Heart Failure Questionnaire, depicting physical activity, somatic symptoms, emotions, and life satisfaction.
In a comparison of patients treated with metoprolol or placebo, patients treated with metoprolol noted a significantly more
favorable response than those treated with placebo in terms of the overall treatment evaluation (p<0.05). Additionally, an
analysis of the changes from baseline to 18 months, using 95% confidence intervals, revealed that patients treated with metoprolol
showed a significant improvement from baseline to 18 months in life satisfaction, physical activity, and the total score,
while patients treated with placebo did not change at all. The improvement in quality of life was supported by the correlations
with improvement in traditional clinical parameters. 相似文献
129.
In the last few years, survival of patients infected with human immunodeficiency virus (HIV) has been improved because of a decreased incidence of some opportunistic complications attributable to prophylactic treatments and antiretroviral drugs. The impact of these agents should also be reflected in the quality of life (QoL) of patients. We have reviewed this topic with an emphasis on different types of measurements such as Q-TWIST, MOS and the Spitzer score which seem to be most appropriate for this patient population. We do not think that a special type of assessment should be designed for HIV-infected persons. It would be less time-consuming to improve already existing validated scores focusing on HIV infection. QoL in intravenous drug users with HIV should be evaluated more often. 相似文献
130.
Estil Y. Strawn Jr. MD Miles J. Novy MD Kenneth A. Burry MD Cynthia L. Bethea PhD 《American journal of obstetrics and gynecology》1995,172(6):1837-1844
Objective: Our purpose was to determine whether insulin-like growth factors I and II preferentially stimulate uterine leiomyoma cells versus myometrial cells in monolayer culture.Study design: Leiomyomas and normal myometrium were obtained at hysterectomy from five premenopausal women. Specimens were enzymatically digested for use in primary monolayer cell cultures. By use of serum-free media, insulin-like growth factor I or II was added in 1, 10, and 100 ng/ml concentrations to both cell types with the patient serving as her own control. Cell number, prolactin production, and proliferative index values were measured on day 15 of cell culture.Results: Significant increases in cell number were found in the leiomyoma cultures (p < 0.05) treated with 10 and 100 ng/ml insulin-like growth factors I but not with insulin-like growth factos II. Neither factor exerted a stimulatory effect on myometrial cells.Conclusion: Insulin-like growth factor sI preferentially stimulates leiomyoma cells in monolayer culture. These results suggest an autocrine-paracine role in vivo for this factor in conjuction with gonadal steroids in promoting leiomyoma growth. 相似文献